Lyme disease, a complex, multisystem disorder caused by Borrelia burgdorferi, is transmitted to humans by ticks of the Lodes ricinus complex (3, 23) . Lyme disease is now the most common tickborne illness in the United States (5) . Its most characteristic clinical feature is an expanding skin lesion called erythema migrans, yet patients with the disease may present with arthritic, cardiac, or neurological symptoms without a skin rash (22) . Clinical pictures vary and are, at times, not distinctive, especially in the absence of erythema migrans.
Determination of antibody levels to B. burgdorferi is the most frequently used laboratory method for the diagnosis of Lyme disease. Established procedures include the indirect fluorescent-antibody test (18, 25) , formats of the enzymelinked immunosorbent assay (7, 18) including the antibody capture assay (2) , and the quantitative fluorescence immunoassay (11, 17) . These procedures, however, have demonstrated a lack of sensitivity, especially in the early stages of disease, and cross-reactivity with other spirochetal or autoimmune diseases (7, 11, 17, 18, 25) . Attempts to improve these tests have focused on the use of antigenic fractions, such as the purified 41-kDa flagellar protein (6, (8) (9) (10) ; incorporation of serum-absorbing agents (12, 16, 25) ; and separate detection and quantitation of immunoglobulin M (IgM) and IgG antibodies (2, 15) .
Multiple laboratories have attempted to improve the serodiagnosis of Lyme disease by use of other methods (2, 6, 15) . Recently, we developed an in vitro borreliacidal assay that accurately reflects the levels of protective antibody as determined by passive transfer of immunity (14, 19, 20 viable B. burgdorferi. Three weeks after infection, hamsters were mildly anesthetized by inhalation of either contained in a nose-and-mouth cup and were bled by intracardiac puncture. The blood was allowed to clot; and the serum was separated by centrifugation at 500 x g, pooled, divided into 1-ml aliquots, and frozen at -70°C until use. Concomitantly, pooled normal serum was obtained from five noninfected hamsters.
Borreliacidal assay. Normal and immune hamster sera were heat inactivated at 56°C for 30 min and serially diluted in fresh BSK. Subsequently, a 3-day culture of B. burgdorferi was diluted with BSK to approximately 6 x 106 spirochetes per ml, and 100-,ul aliquots were added to 1.5-ml microcentrifuge vials containing 100 ,ul of heat-inactivated normal or immune serum. Sterile guinea pig serum (10 RIl), which was absorbed with protein A, with a complement activity of 325 50% hemolytic complement units per ml (GIBCO) was added, yielding a final antiserum dilution of 1:20. BSK inoculated with 100 RI of a solution containing 6 x 105 B. burgdorfen was included as an additional control. All assay tubes were gently shaken and incubated at 32°C for 2 to 6 h. After incubation, 10-,ul aliquots were removed in triplicate and mounted onto clean glass slides, and the total numbers of live and dead spirochetes were determined. Twenty-five random fields of each 10-pul aliquot were read at x400 magnification by using dark-field microscopy. Spirochetes which exhibited motility were considered viable (13 To focus the Lyme disease spirochete and reduce signal variability in forward and side scatter, the sample fluid flow rate was set to 12 p.1/min. Nonrectangular gates on the forward-versus side-scatter dot plots were used to identify bacterial organisms for analysis.
Anti-OspA. Monoclonal antibody to OspA (hybridoma H3TS; Symbicom, Umea, Sweden), the 31-kDa protein of B. burgdorferi, was used to label the Lyme disease spirochete. Briefly, 107 B. burgdorferi per ml were incubated with anti-OspA (1:100) for 30 min at 32°C and were then incubated with fluorescein isothiocyantate-conjugated anti-mouse IgG antibody (1:8,000; Sigma) for 30 min at 32°C.
Statistics. An unpaired, two-sample t test was used to compare differences in the sample flow rate and the mean channel of light-scatter and propidium iodide fluorescence profiles. The standard deviation of duplicate samples was used to estimate variance. burgdorferi organisms were analyzed by flow cytometry to determine whether spirochetes could be identified on a plot of forward versus side light scatter. Spirochetes were detected in aliquots containing B. burgdorferi (Fig. 1A ) when they were compared with samples containing only BSK (Fig.  1B) . Nonrectangular analysis gates were drawn around these spirochetes, and all subsequent analyses were performed on events within this gate.
To confirm that the gated events detected in BSK containing Lyme disease spirochetes were B. burgdorferi, aliquots were treated with anti-OspA monoclonal antibody, an antibody specific for B. burgdorfen, and fluorescein isothiocyanate-conjugated anti-mouse IgG. Fluorescence histograms demonstrated that an increase in green fluorescence occurred in aliquots containing B. burgdorferi treated with anti-OspA ( Fig. 2A) . In the absence of anti-OspA treatment, the intensity of green fluorescence was 10-fold lower. When aliquots containing B. burgdorferi and complement without anti-OspA were incubated at 56°C for 30 min and labeled with propidium iodide, a similar increase in the intensity of red fluorescence was detected (Fig. 2B) .
Effects of immune serum on characteristics ofB. burgdorferi detected by flow cytometry. Four flow cytometric parameters A were evaluated. These included side-scattered light, staining with propidium iodide, the number of gated events per second, and forward-scattered light. When normal or immune sera were incubated with B. burgdorfen and complement for 2, 4, and 6 h, significant differences in side scatter were detected at each time interval (Fig. 3A) . The greatest difference between the effects of immune serum and normal serum was detected after incubation for 6 h. Similar findings were obtained by using forward-scatter light (Fig. 3B) , except that no significant difference occurred at 2 h when propidium iodide fluorescence (Fig. 3C ) and sample flow rate (Fig. 3D) (14) . When 29 ml of fresh BSK was added to these suspensions and incubated for 3 weeks, the number of motile spirochetes was significantly less than that in the controls (Fig. 4) .
In addition, changes in side scatter and propidium iodide fluorescence demonstrated the specificity of immune serum effects. When immune serum directed against isolate 297 was incubated with B. burgdorferi isolates 297, G25, and PBi, only isolate 297 was affected (Table 1) . No significant differences in the flow cytometric parameters were detected when isolates G25 and PBi were incubated in anti-297 or normal serum.
DISCUSSION
Our results show that flow cytometric measurements, specifically side and forward scatter, propidium iodide fluorescence, and sample flow rate, can be used as determinants of borreliacidal activity. Most importantly, these measurements could be obtained within hours of incubating B. burgdorfen organisms with immune serum and complement. In addition, the cytometric measurements were useful for identifying antibody specificity between isolates of B. burgdorferi and immune serum.
These results correlated well with results of our previous studies in which we used passive transfer of immune serum to confer protection on irradiated hamsters challenged with B. burgdorfen (19, 20) and determined the ability of the same immune serum to kill B. burgdorferi in vitro (14 burgdorfen.
Our results also showed that flow cytometric analysis could distinguish among isolates of B. burgdorferi. Immune serum raised against B. burgdorfen isolate 297 affected the homologous isolate but not other isolates of B. burgdorfen. These findings are important, since flow cytometric analysis may be a rapid method for defining related groups of B. burgdorferi for epidemiological studies, serodiagnosis, or development of a vaccine.
In conclusion, flow cytometry is valuable for determining the effects of immune serum on B. burgdorferi. Additional studies are needed to determine whether serum from patients with Lyme disease can exert a similar effect on B. burgdorferi. Recently, Callister et al. (4) showed that patients with Lyme disease produce borreliacidal antibody.
Flow cytometry promises to be a rapid means of determining the presence of borreliacidal activity and to lead to a better serodiagnostic test.
